Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
BEDFORD, Mass., Sept. 27 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the maker of the OmniPod® Insulin Management System, today announced that it has been awarded a home medical equipment accreditation from the Community Health Accreditation Program (CHAP) for achieving the organization's Standards of Excellence. CHAP is an independent, non-profit national accrediting body that is a leader in improving the quality of home and community-based health care organizations in the United States.
The OmniPod System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and virtually pain-free automated insertion. The System consists of the compact, lightweight OmniPod, which is worn discreetly beneath clothing and delivers insulin based on instructions from its wireless companion, the easy-to-use, handheld Personal Diabetes Manager (PDM). The PDM contains a fully integrated FreeStyle® blood glucose meter and is very similar in materials, construction and appearance to a personal digital assistant. The System is available in the eastern and mid-western U.S. and on the U.S. west coast
"We're honored to receive this recognition from CHAP and believe it demonstrates Insulet's commitment to providing a high-quality device with outstanding support services to our customers," said Duane DeSisto, President and Chief Executive Officer of Insulet. "Increasingly, insurance providers are requiring independent, third party validation of a product's quality standards in order to approve it for reimbursement. We expect that Insulet's CHAP accreditation will enable more people with insulin-dependent diabetes to gain access to OmniPod."
CHAP accreditation publicly certifies that an organization has voluntarily met the highest standards of excellence for home and community-based health care. Its Standards of Excellence are driven by considerations of quality, management, client outcomes, adequate resources, and long-term viability.
In 2006, CHAP was granted regulatory authorization by the Centers for Medicare and Medicaid Services to survey organizations providing home medical equipment to determine whether they meet the Medicare Conditions of Participation.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.
Paul Kidwell, Lazar Partners for Insulet Corporation, Tel. +1-617-296-3854
Mark Sahl, Lazar Partners for Insulet Corporation, Tel. +1-646-871-8485 or
SOURCE Insulet Corporation